Arsenic is a natural element found in the earth’s crust and is extensively present in various environmental components. Anthropogenic activities and a few natural events have generated contaminants that have led to massive environmental pollution, one form of which is arsenic contamination. Arsenic enters the human food chain via contaminated crops, water, seafood, and dairy products. In Pakistan, the increasing concentration of arsenic in the water is causing major health problems. Due to the serious health risks posed by arsenic, it is crucial to design and implement strategies for reducing and preventing the bioaccumulation of arsenic and its entry into the human food chain. There is a need for an institutional framework for arsenic mitigation, accountability, and systemic checks and balances. Targeted short- and long-term policies are required for effective and sustainable management.

Background: The Internet of Things (IoT) has emerged as a transformative force in healthcare, offering significant potential to enhance patient care through connected devices. Understanding the research trends and contributions in this field is crucial for guiding future innovations. Objective: This bibliometric review investigates the evolution of IoT applications in healthcare, focusing on their impact on patient management, treatment outcomes, and healthcare delivery.

Background: Cardiovascular disease (CVD) is a major global health issue, contributing significantly to morbidity, mortality, and economic burden. Despite medical advancements, developing effective cardiovascular drugs remains challenging due to the complexity of these disorders and the high failure rates in clinical trials. Traditional drug discovery methods, reliant on empirical testing, are often slow and inefficient. Objective: This book examines the transformative potential of artificial intelligence (AI) in addressing the challenges of cardiovascular drug discovery. It aims to elucidate how AI can improve drug development processes and enhance personalized medicine. Methods: The book reviews AI's applications throughout the drug discovery process, from target identification to clinical trials. It integrates case studies, expert opinions, and real-world examples to illustrate AI's impact on improving drug design, predictive accuracy, and therapeutic outcomes. Results: AI has demonstrated significant promise in revolutionizing cardiovascular drug discovery. In analyzing extensive biomedical data, AI enables the identification of novel patterns and insights that traditional methods may overlook. This facilitates more effective target identification, drug design, and prediction of drug efficacy and safety. Conclusion: The integration of AI into cardiovascular drug discovery offers substantial potential to overcome existing limitations, streamline the development process, and improve patient outcomes. The book underscores the role of AI in reshaping cardiovascular healthcare and addressing the global burden of CVD.

Introduction: This paper presents a bibliographic review aimed at enhancing the understanding of Performance Evaluation in Human Resources Management and proposes an innovative model based on human motivation to develop Competency Management in HR management. Traditional Views on Performance Evaluation: Traditionally, Performance Appraisals have been viewed solely as tools for determining salary increments or employment termination. However, this paper argues for a novel approach to performance evaluation that emphasizes human motivation and its implications in achieving common organizational objectives. Competencies and their Historical Evolution: Competencies are defined as observable and measurable behaviours that combine knowledge, skills, and abilities to achieve desired results. Originating from various sources such as training, experience, and learning, competencies have been studied since the late 1960s to predict job performance effectively and address biases in traditional evaluation methods. Competency Management Model: The Competency Management Model offers a holistic approach to human resource management, focusing on defining professional profiles, developing skilled teams, identifying weaknesses for improvement, and establishing measurable performance standards. Performance Evaluation in the Competency Management Model: Performance Evaluation within the Competency Management framework emphasizes job performance rather than mere exam scores. It serves as a diagnostic tool to gather evidence of individual performance and knowledge, facilitating personal and organizational development. Differentiating Competency Evaluation from Other Models: Evaluation by Competencies differs from other evaluation models by focusing on job performance, increasing staff commitment, fostering communication, and promoting self-management and autonomy among workers. New Management of Human Resources: As organizations navigate through the complexities of the 21st century, strategic management of human resources becomes crucial for maintaining competitiveness. Human capital emerges as the primary source of competitive advantage, necessitating a shift towards a strategic approach to HR management. Conclusion: The integration of Performance Evaluation with Competency Management presents opportunities for organizations to enhance productivity, achieve organizational goals, and foster a culture of excellence. By strategically managing human resources, organizations can adapt to changes effectively and capitalize on the strengths of their workforce in the globalized and competitive landscape.

Introduction: Treating illnesses caused by enterobacteria is increasingly challenging due to the ineffectiveness of antibiotics in combating pathogens or promoting reticuloendothelial system cell phagocytosis, especially for bacteria that colonize and grow inside phagocytic cells. Certain antibiotics are unable to penetrate cells or are limited by the plasma membrane. Consequently, there is a scientific effort to develop new therapeutic strategies to overcome these challenges. Lipid nanocarriers, such as liposomes, can encapsulate antibiotics to enhance their delivery, targeting, and efficacy. Liposomes aim to improve the specificity of release, concentration of compounds at the target site, maintenance of drug plasma concentration, and preservation of active components. This review aims to outline the key characteristics of liposomes and emphasize the benefits of using these lipid vesicles to deliver antibiotics against illnesses caused by enterobacteria. Methodology: A literature review was conducted by searching national and international electronic databases for articles published between 2012 and 2023. Articles were selected based on the following descriptors: bacterial resistance, nanotechnology, gram-negative bacteria, and antibiotics. Findings: Antibacterial activity has been demonstrated for cationic and stealth liposomes, primarily composed of cholesterol, PEG, phosphatidylcholine, and carboxymethyl chitosan encapsulating drugs such as amoxicillin, ciprofloxacin, cloxacillin, vancomycin, azithromycin, amoxicillin, cefepime, gentamicin, and cefotaxime. Liposomes containing polymyxin B, azithromycin, chloramphenicol, and gentamicin have shown improved antibiofilm efficacy against enterobacteria compared to non-encapsulated pharmaceuticals. Conclusion: The findings highlight the significant therapeutic potential of liposomes in the management of enterobacteria-related illnesses.

Cardiovascular disease (CVD) is a predominant concern for individuals diagnosed with diabetes mellitus, representing a leading cause of morbidity and mortality. This review delves into the complex interplay between diabetes and cardiovascular problems, offering insights into preventative interventions and treatment strategies. Drawing from current research, this comprehensive review evaluates methods to reduce cardiovascular risk in individuals with diabetes. The analysis focuses on insulin resistance as a pivotal factor linking diabetes to CVD, leading to dyslipidemia and atherogenesis, thereby elevating the risk of cardiovascular events. Patients with diabetes face an increased risk of cardiovascular events due to the intricate relationship between insulin resistance, dyslipidemia, and atherogenesis. Moreover, hyperglycemia-induced oxidative stress and inflammation contribute to endothelial dysfunction, fostering vascular damage and elevating the risk of cardiovascular issues. The correlation between diabetes and CVD accelerates atherosclerotic plaque formation, rendering the plaque more prone to rupture and causing severe cardiovascular problems like myocardial infarction and stroke. Understanding the nuanced connection between diabetes and cardiovascular disease is paramount for developing effective interventions. This narrative review synthesizes evidence-based preventative measures and treatment choices, providing valuable insights for healthcare practitioners. The aim is to enhance patient outcomes, improve quality of life, and reduce mortality rates in individuals with diabetes and coexisting CVD. The review serves as a comprehensive resource for healthcare professionals and academics, laying the groundwork for innovative approaches in diabetes management through an in-depth exploration of current research and underlying processes.